A subscription to JoVE is required to view this content. Sign in or start your free trial.

Research Article

Effect of Post-Discharge Oral Nutritional Supplements on Nutritional Status in Patients after Gastrectomy: A Systematic Review and Meta-Analysis

90 views

⸱

DOI:

10.3791/70912

⸱

September 1st, 2026

 , 

Corresponding Authors: Wenqing Xu <xcz70517824@163.com>

In This Article

Summary

This study evaluates post-discharge oral nutritional supplementation for patients with gastric cancer following gastrectomy. The evidence suggests that supplementation may mitigate postoperative weight loss during early-to-intermediate recovery, particularly after total gastrectomy, without an apparent increase in adverse events; however, effects on body composition, handgrip strength, laboratory markers, and durable long-term outcomes remain uncertain.

Abstract

Nutritional intervention after gastrectomy is central to postoperative recovery, but the optimal outpatient supplementation strategy remains uncertain. This systematic review assessed the efficacy and safety of oral nutritional supplementation (ONS) after hospital discharge in patients undergoing gastrectomy for gastric cancer. Eligible randomized controlled trials (RCTs) were identified from five databases through September 2025. Extracted outcomes included adverse events, laboratory indices, body composition, handgrip strength, and body-weight change. Seven RCTs involving 1,736 participants met the review criteria, although the number of trials contributing to each pooled outcome varied. ONS significantly attenuated absolute body-weight loss (WMD: 0.75 kg; 95% CI: 0.11 to 1.40) and percentage body-weight loss (WMD: 1.42; 95% CI: 0.78 to 2.07) compared with control care. Risk-of-bias assessment identified generally adequate randomization and allocation reporting in most trials, but certainty remains limited by the small number of trials, substantial heterogeneity in the primary weight outcome, and the absence of a formal GRADE assessment. No significant inter-group differences were found for body composition, handgrip strength, or laboratory markers. Adverse-event incidence was not significantly different between groups when analyzed with the fixed-effect model selected for minimal heterogeneity (RR: 1.17; 95% CI: 0.92 to 1.49). These findings suggest that post-discharge ONS may help reduce early to intermediate postoperative weight loss after gastrectomy without a clear safety penalty. Because most endpoints were assessed between 8 weeks and 3 months, the durability of benefit beyond this period remains unclear.

Introduction

Gastric cancer remains a substantial global health burden and an important cause of cancer-related mortality. According to GLOBOCAN 2022 estimates, gastric cancer continues to rank among the leading causes of cancer incidence and death worldwide1. Although chemotherapy, targeted therapy, and immunotherapy have improved, gastrectomy remains a main curative option for locally advanced proximal tumors, diffuse-type disease, and selected other gastric cancers. It is also used prophylactically to reduce cancer risk in individuals carrying CDH1 mutations2. However, removal of all or part of the stomach changes gastrointestinal....

Access restricted. Please log in or start a trial to view this content.

Protocol

This systematic review and meta-analysis used only previously published aggregate data and did not involve direct contact with human participants or access to identifiable patient-level information. Institutional review board approval and informed consent were therefore not required. The software and databases used are listed in the Table of Materials.

Registration and search strategy
The review followed the PRISMA 2020 reporting framework during the planning, conduct, and reporting stages, and the preregistered PROSPERO protocol (CRD420251245644) was used to guide the eligibility criteria, outcomes, ....

Access restricted. Please log in or start a trial to view this content.

Results

Search results and patient characteristics
Figure 1 presents the PRISMA 2020 screening workflow. Database searches identified 214 records (PubMed, n = 53; Web of Science, n = 64; Embase, n = 47; Cochrane Library, n = 27; China National Knowledge Infrastructure, n = 23). No register or other-source records were identified. After 65 duplicate records were removed, 149 records were screened. Seventy-nine records were excluded during title and abstract screening, leaving 70 .......

Access restricted. Please log in or start a trial to view this content.

Discussion

Gastrectomy remains a major curative treatment for localized gastric cancer and has important implications for postoperative recovery and prognosis29. Reduced gastric capacity, altered gastrointestinal motility, impaired nutrient absorption, and surgical stress can lead to inadequate energy intake, weight loss, and deterioration in nutritional status30,31. These changes may affect postoperative complications, chemotherapy tolerance, treatm.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

Gratitude is expressed to colleagues at Xi'an Jiaotong University and Fudan University for general support and valuable suggestions during manuscript preparation. Appreciation is also extended to the reviewers and editors for constructive comments that significantly improved the quality of this work. The authors declare that no specific grant was received from any funding agency in the public, commercial, or not-for-profit sectors.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
China National Knowledge Infrastructure (CNKI)CNKIhttps://www.cnki.net/Chinese-language literature database searched for eligible records
Cochrane LibraryCochrane / Wileyhttps://www.cochranelibrary.com/Systematic review and clinical trial database searched for eligible records
Cochrane Risk of Bias frameworkCochrane Methodshttps://methods.cochrane.org/bias/Domain-level risk-of-bias assessment for randomized controlled trials
EmbaseElsevierhttps://www.embase.com/Biomedical and pharmacological literature database searched for eligible records
EndNoteClarivateVersion 21; https://endnote.com/Reference management and citation formatting
GRADE approachGRADE Working Grouphttps://www.gradeworkinggroup.org/Certainty-of-evidence framework discussed in the limitations
PRISMA 2020 reporting guidelinePRISMA Statementhttps://www.prisma-statement.org/Reporting framework for the systematic review and PRISMA flow diagram
PROSPERO registryCentre for Reviews and Dissemination, University of YorkCRD420251245644; https://www.crd.york.ac.uk/prospero/Prospective registration record for the systematic review protocol
PubMedNational Library of Medicine / NCBIhttps://pubmed.ncbi.nlm.nih.gov/Biomedical literature database searched for eligible trials
R package: metaCRAN / R package authorshttps://cran.r-project.org/package=metaMeta-analysis functions for pooled effect estimates and forest plots
R package: metaforCRAN / Wolfgang Viechtbauerhttps://cran.r-project.org/package=metaforSupplementary meta-analysis calculations and heterogeneity checks
R softwareR Foundation for Statistical ComputingVersion 4.5.1; https://www.r-project.org/Statistical environment for meta-analysis and sensitivity checks
Web of ScienceClarivatehttps://www.webofscience.com/Citation and multidisciplinary literature database searched for eligible records

References

  1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-263.
  2. Zou ZH, Zhao LY, Mou TY, Hu YF, Yu J, Liu H, et al. Laparoscopic vs open D2 gastrectomy for locally advanced gastric cancer: a meta-analysis. World J Gastroenterol. 2014;20(44):16750-16764.
  3. Agnes A, Ricci R, D'Ugo D, Persiani R, Rausei S, et al. Symptoms, nutritional outcomes and quality of life after total gastrectomy with Roux-en-Y reconstruction: results of a cross-sectional study conducted on 80 long-term survivors. Updates S....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Post-Discharge NutritionGastrectomy PatientsGastric CancerBody-Weight LossRandomized Controlled TrialsPostoperative Recovery